• 해양환경안전학회지
• /
• 제15권1호
• /
• pp.71-78
• /
• 2009

해양환경관리공단은 MARPOL 73/78에 따른 해양환경 보전을 위하여 1998년 정부로부터 전국 13개 주요 항만에 위치한 선박폐수 처리시설을 위탁받아 운영해왔다. 이 시설은 선박폐수를 처리함에 있어 단순히 해양환경관리법에서 정한 유분농도(n-H 광유류) 15ppm을 충족할 수 있도록 설계되어 운영되어 왔다. 그러나 선박폐수에는 n-H 광유류 뿐만 아니라 유기물에 의한 악취와 각종 불순물이 함유되어 있기 때문에 이들이 처리되지 않고 그대로 해양에 배출됨으로써 해양오염은 물론 주변 인가 등으로부터 민원의 대상이 되었다. 이에 따라 공단은 지난 2007년 선박폐수 처리공정 개선 작업을 시행하여 새로운 수처리 약품을 개발하여 적용하고, 오존을 이용하여 기존의 공정을 3${\sim}$4 단계 줄이면서도 배출수의 유분농도 뿐만 아니라 콜로이드물질, ABS, 인, 질소 등 난분해성 유기물질과 미생물 분해에 의한 악취를 효과적이고 혁신적으로 저감 시킬 수 있는 새로운 공정을 개발하여 현장에 적용시켰다. 새로운 공정은 각종 오염물질과 악취를 획기적으로 제거할 뿐만 아니라 공정의 단순화를 통해 시설 유지비 10% 이상 절감 등 13개 선박폐수 처리시설 운영비를 매년 1억6천만원 이상 줄일 수 있는 획기적인 공정으로 방법특허를 출원하였다.

• Nutrition Research and Practice
• /
• 제9권2호
• /
• pp.129-136
• /
• 2015

BACKGROUND/OBJECTIVES: A variety of immunomodulators can improve the efficacy of low-dose chemotherapeutics. Active hexose correlated compound (AHCC), a mushroom mycelia extract, has been shown to be a strong immunomodulator. Whether AHCC could enhance the antitumor effect of low-dose 5-fluorouracil (5-FU) via regulation of host immunity is unknown. MATERIALS/METHODS: In the current study Hepatoma 22 (H22) tumor-bearing mice were treated with PBS, 5-FU ($10mg{\cdot}kg^{-1}{\cdot}d^{-1}$, i.p), or AHCC ($360mg{\cdot}kg^{-1}{\cdot}d^{-1}$, i.g) plus 5-FU, respectively, for 5 d. $CD^{3+}$, $CD^{4+}$, $CD^{8+}$, and NK in peripheral blood were detected by flow cytometry. ALT, AST, BUN, and Cr levels were measured by biochemical assay. IL-2 and $TNF{\alpha}$ in serum were measured using the RIA kit and apoptosis of tumor was detected by TUNEL staining. Bax, Bcl-2, and TS protein levels were measured by immunohistochemical staining and mRNA level was evaluated by RT-PCR. RESULTS: Diet consumption and body weight showed that AHCC had no apparent toxicity. AHCC could reverse liver injury and myelosuppression induced by 5-FU (P < 0.05). Compared to mice treated with 5-FU, mice treated with AHCC plus 5-FU had higher thymus index, percentages of $CD^{3+}$, $CD^{4+}$, and NK cells (P < 0.01), and ratio of $CD^{4+}$/$CD^{8+}$ (P < 0.01) in peripheral blood. Radioimmunoassay showed that mice treated with AHCC plus 5-FU had the highest serum levels of IL-2 and $TNF{\alpha}$ compared with the vehicle group and 5-FU group. More importantly, the combination of AHCC and 5-FU produced a more potent antitumor effect (P < 0.05) and caused more severe apoptosis in tumor tissue (P < 0.05) compared with the 5-FU group. In addition, the combination of AHCC and 5-FU further up-regulated the expression of Bcl-2 associated X protein (Bax) (P < 0.01), while it down-regulated the expression of B cell lymphoma 2 (Bcl-2) (P < 0.01). CONCLUSIONS: These results support the claim that AHCC might be beneficial for cancer patients receiving chemotherapy.

• Asian Pacific Journal of Cancer Prevention
• /
• 제16권6호
• /
• pp.2431-2440
• /
• 2015

Background: Registry data from four major public hospitals indicate trends in clinical care and survival from colorectal cancer over three decades, from 1980 to 2010. Materials and Methods: Kaplan-Meier productlimit estimates and Cox proportional hazards models were used to investigate disease-specific survival and multiple logistic regression analyses to explore first-round treatment trends. Results: Five-year survivals increased from 48% for 1980-1986 to 63% for 2005-2010 diagnoses. Survival increases applied to each ACPS stage (Australian Clinico-Pathological Stage), and particularly stage C (an increase from 38% to 68%). Risk of death from colorectal cancer halved (hazards ratio: 0.50 (0.45, 0.56)) over the study period after adjusting for age, sex, stage, differentiation, primary sub-site, health administrative region, and measures of socioeconomic status and geographic remoteness. Decreases in stage were not observed. Survivals did not vary by sex or place of residence, suggesting reasonable equity in service access and outcomes. Of staged cases, 91% were treated surgically with lower surgical rates for older ages and more advanced stage. Proportions of surgical cases having adjuvant therapy during primary courses of treatment increased for all stages and were highest for stage C (an increase from 5% in 1980-1986 to 63% for 2005-2010). Radiotherapy was more common for rectal than colonic cases. Proportions of rectal cases receiving radiotherapy increased, particularly for stage C where the increase was from 8% in 1980-1986 to 60% in 2005-2010. The percentage of stage C colorectal cases less than 70 years of age having systemic therapy as part of their first treatment round increased from 3% in 1980-1986 to 81% by 1995-2010. Based on survey data on uptake of adjuvant therapy among those offered this care, it is likely that all these younger patients were offered systemic treatment. Conclusions: We conclude that pronounced increases in survivals from colorectal cancer have occurred at major public hospitals in South Australia due to increases in stage-specific survivals. Use of adjuvant therapies has increased and the patterns of change accord with clinical guideline recommendations. Reasons for sub-optimal use of radiotherapy for rectal cases warrant further investigation, including the potential for limited rural access to impede uptake of treatments at metropolitan-based radiotherapy centres.

• Asian Pacific Journal of Cancer Prevention
• /
• 제16권6호
• /
• pp.2355-2359
• /
• 2015

Background: Combination chemotherapy of 5 fluorouracil (5-FU) and leucovorin (LV) with oxaliplatin, mainly FOLFOX regimens, has shown considerable antitumor activity and a tolerable toxicity profile in gastric cancer. The goal of this study was to retrospectively compare the efficacy and toxicity of modified FOLFOX-6 (mFOLFOX6) regimen in advanced gastric cancer (AGC) patients with good and poor performance status (PS). Materials and Methods: AGC patients receiving the mFOLFOX6 regimen including oxaliplatin $85mg/m^2$, bolus of 5-FU $400mg/m^2$ and LV $400mg/m^2$ on the first day, followed by $2400mg/m^2$ of 5- FU as a continious infusion over 46 hour for first-line treatment were eligible for the study. Results: A total 58 patients with a median age of 59.5 (32-81) were included. The median follow up of the study was 9.2 months. Thirty patients (51.7%) with an ECOG PS 0-1 were assigned to the good PS arm, while 28 patients (48.3%) with ECOG PS 2 were in the poor PS arm. Overall response rates were 36.6 and 28.8%, respectively (p=0.91). Median PFS was 6.7 and 6.3 months in good PS and poor PS arms (p=0.50) and median OS was 9.6 and 10.4 months (p=0.55). As compared with good PS arm, poor PS arm was associated with more grade 3-4 neutropenia and anemia. Dose reduction and dose delays were also significantly higher. Conclusions: In this study, mFOLFOX6 was similarly effective in both arms. Although hematologic toxicity was significantly higher in patients with poor PS, it remained manageable. Our results suggest that this regimen may be an effective treatment option for AGC patients with poor PS.

• Asian Pacific Journal of Cancer Prevention
• /
• 제15권23호
• /
• pp.10277-10280
• /
• 2015

Background and Aim: Breast cancer (BC) is a heterogeneous disease and cell proliferation markers may help to identify subtypes of clinical interest. We here analyzed the correlation between cell proliferation determined by Ki67 and HG in BC patients undergoing preoperative chemotherapy (PCT). Materials and Methods: We obtained clinical/pathological data from patients with invasive BC treated at our institution from 1999 until 2012. Expression of estrogen receptor (ER), progesterone receptor (PR), epidermal growth factor receptor type 2 (HER2) and Ki67 were determined by immuno-histochemistry (IHC). Clinicopathological subtypes were defined as: Luminal A, ER and/or PR positive, HER2 negative, HG 1 or 2; Luminal B, ER and/or PR positive, HER2 negative or positive and/or HG 3; triple negative (TN), ER, PR and HER2 negative independent of HG; HER2 positive, ER, PR negative and HER2 positive, independent of HG. By using Ki67, a value of 14% separated Luminal A and B tumors, independently of the histological grade. We analyzed correlations between Ki67 and HG, to define BC subtypes and their predictive value for response to PCT. Results: 1,560 BC patients were treated in the period, 147 receiving PCT (9.5%). Some 57 had sufficient clinicopathological information to be included in the study. Median age was 52 years (26-72), with 87.7% invasive ductal carcinomas (n=50). We performed IHC for Ki67 in 40 core biopsies and 50 surgical biopsies, 37 paired samples with Ki67 before and after chemotherapy being available. There was no significant correlation between Ki67 and HG (p=0.237), both categorizing patients into different subtypes. In most cases Ki67 decreased after PCT (65.8%). Only 3 patients had pathologic complete response (cPR). Conclusions: In our experience we did not find associations between Ki67 and HG. Determination of clinicopathological luminal subtypes differs by using Ki67 or HG.

• Asian Pacific Journal of Cancer Prevention
• /
• 제15권22호
• /
• pp.9599-9602
• /
• 2014

Background: Postoperative adjuvant radiotherapy (RT) in the management of early stage endometrial cancer (EC) is still controversial. Here we report our institutional experience with patients who received postoperative RT for stage I-II EC over a period of 35 years and assess potential predictors of local recurrence (LR), distant metastasis (DM), and overall survival (OS). Materials and Methods: A total of 188 patients undergoing postoperative RT for stage IA-II EC between 1977 and 2012 were evaluated. Some 96 received median 46 Gy whole pelvic radiotherapy (WPRT) (range: 40-60 Gy), 37 were given WPRT with vaginal cuff therapy (VCT), and 55 received only VCT either with brachytherapy (BT) or stereotactic body radiotherapy (SBRT). Chemotherapy was given to 5 patients with uterine papillary serous carcinoma (UPSC). Logistic regression analysis was used to assess the effect of clinicopathological factors on LR, DM, and OS. Results: Median follow-up time was 11 years (range: 1-35 years). At the time of analysis, 34 patients were not alive. Of the 15 patients with LR, 7 (46.7%) recurred in the vaginal stump, 5 (33.3%) in the pelvic region, and 3 (20%) in the paraaortic nodal region, while 12 had distant metastasis. UPSC histology (p=0.027), sole VCT (p=0.041), high histologic grade (p=0.034), and age ${\geq}71$ (p=0.04) were poor prognostic factors on univariate analysis. Conclusions: In our patients receiving radiotherapy for early-stage EC, grade III disease and age ${\geq}71$ were associated with shorter OS whereas UPSC histology was an independent predictor for both LR and DM.

• Asian Pacific Journal of Cancer Prevention
• /
• 제14권12호
• /
• pp.7143-7147
• /
• 2013

Background: The survival outcomes for women presenting with early breast cancer are influenced by treatment decisions. In Malaysia, survival outcome is generally poor due to late presentation. Of those who present early, many refuse treatment for complementary therapy. Objective: This study aimed to explore the decision making experiences of women with early breast cancer. Materials and Methods: A qualitative study using individual in-depth interviews was conducted to capture the decision making process of women with early breast cancer in Malaysia. We used purposive sampling to recruit women yet to undergo surgical treatment. A total of eight participants consented and were interviewed using a semi-structured interview guide. These women were recruited from a period of one week after they were informed of their diagnoses. A topic guide, based on the Ottawa decision support framework (ODSF), was used to facilitate the interviews, which were audio recorded, transcribed and analysed using a thematic approach. Results: We identified four phases in the decision-making process of women with early breast cancer: discovery (pre-diagnosis); confirmatory ('receiving bad news'); deliberation; and decision (making a decision). These phases ranged from when women first discovered abnormalities in their breasts to them making final surgical treatment decisions. Information was vital in guiding these women. Support from family members, friends, healthcare professionals as well as survivors also has an influencing role. However, the final say on treatment decision was from themselves. Conclusions: The treatment decision for women with early breast cancer in Malaysia is a result of information they gather on their decision making journey. This journey starts with diagnosis. The women's spouses, friends, family members and healthcare professionals play different roles as information providers and supporters at different stages of treatment decisions. However, the final treatment decision is influenced mainly by women's own experiences, knowledge and understanding.

• 대한정형외과스포츠의학회지
• /
• 제11권1호
• /
• pp.24-29
• /
• 2012

목적: 상완 이두근 장두의 고정술을 시행하는데 있어 관절경을 이용한 간섭 나사못(interference screw) 고정술후의 임상적 결과를 분석하고자 하였다. 대상 및 방법: 2008년 1월부터 2010년 1월까지 상완 이두근 장두의 건 고정술을 시행한 환자를 대상으로 하였으며, 최소 1년 이상 추시가 가능하였던 30예를 대상으로 하였다. 그중 회전근개 파열을 동반한 경우는 20예였다. 결과는 VAS, ASES, 상완 이두근 구의 압통, 고정실패 및 변형의 정도로 판단하였다. 결과: 최종 추시시 모든 환자에서 수술 전에 비해서 VAS, ASES 점수는 의미 있게 호전되었으나(p<0.05), 최종 추시시 17%(5예)에서 상완 이두근 구의 통증이 존재하였고, 10%(3예)에서 고정실패 및 BAD (biceps apex distance)의 증가로 인한 Popeye 변형이 존재하였다. 또한 회전근개 파열을 동반한 군과 그렇지 않는 군에서는 최종 추시시 회전근개 파열이 없는 군에서 좋은 결과를 얻을 수 있었다(p<0.05). 결론: 상완 이두근 근위부 병변에 의한 통증이 있는 환자에서 관절경적 상완 이두근 장두의 건고정술은 모두 최종 추시시 좋은 결과를 얻을 수 있으나, 17%에서 상완 이두근 구의 압통이 존재하여 추가적인 연구가 필요할 것으로 사료된다.

• 한국수산과학회지
• /
• 제47권5호
• /
• pp.582-587
• /
• 2014

We investigated the effects of feeding rate on the growth, blood components, and histology of sub-adult olive flounder Paralichthys olivaceus. Optimum feeding rate (initial fish mean weight : $384.2{\pm}5.91g$) was determined under the optimum water temperature. Two replicated groups of fish were fed a commercial diet at rates of 0%, 0.3%, 0.5%, and 0.7% body weight (BW) per day, and to satiation. The feeding trial was conducted using a flow-through system with ten 1.2-metric ton aquaria receiving filtered seawater at $20-24.5^{\circ}C$ for 3 weeks. After the feeding trial, the weight gain (WG) and specific growth rate (SGR) were significantly higher in fish fed at 0.7% BW/day and those fed to satiation (0.9% BW/day) than in fish fed at other feeding rates or in the unfed fish. These parameters were negative and significantly lower in the unfed fish than in those fed the experimental diet at all feeding rates. There were no significant differences in WG and SGR among fish fed at 0.3 and 0.5% BW/day and among those fed at 0.7% BW/day and to satiation. The histological changes in the hepatopancreas, kidney, and anterior intestine of fish fed at 0, 0.5, and 0.9 % BW/day did not differ much. Broken-line regression analysis of weight gain showed that the optimum feeding rate of olive flounder weighing 384 g was 0.74% BW per day at the optimum water temperatures.

• 대한방사선치료학회지
• /
• 제18권2호
• /
• pp.67-73
• /
• 2006

목 적: 암 환자의 증가와 함께 방사선 치료기술도 날로 발전하고 있으며 이로인해 치료를 위해 사용되는 영상 및 데이터의 양들도 대폭 증가하는 결과를 가져오게 되어 이들을 저장, 보관, 관리하는데 많은 어려움이 있었다. 이러한 문제점 해결을 위해 과에서 발생되는 모든 영상 및 data의 PACS (picture archiving and communication system)화를 목적으로 의료정보팀의 협조 하에 본 System을 개발, 적용하게 되었다. 대상 및 방법: 본과 방사선치료 관리 시스템(RO-radiation oncology)에서 PACS에 접근할 수 있는 code를 부여한 후 영상은 R&V (Record and Verify: Varis vision, Varian, USA) 시스템 및 planning system에서 export 한다. 이때 DICOM (digital image and communication system) head에 있는 많은 정보들 중에서 필요한 정보를 이용하여 프로그램화 하였다. 결 과: 방사선종양학과에서 발생되는 모든 영상 및 자료 즉, 모의치료, CT, L-gram 영상, structure (normal organ & target volume), DRR (Digital Reconstruction Radiography), 선량 분포도, DVH (dose volume histogram) 등을 PACS에 구현 하였으며 과내 어느 컴퓨터에서도 선명히 영상을 볼 수 있고 출력할 수 있도록 하였다. 결 론: 본 시스템의 개발로 film less화가 가능하게 되어 현상 처리에 관련한 암실 공간과 유지비용이 소멸되었고 film 저장공간 및 film을 찾는데 소요되는 인력과 시간을 포함한 유, 무형의 경제적 비용뿐만 아니라 영상 저장을 위한 별도의 저장장치의 구입도 불필요하게 되었다. 아울러 방사선 치료를 위해 복잡하게 행해졌던 일련의 과정들이 본 시스템을 통해서 현재는 전산 상에서 쉽게 처리할 수 있게 되어 업무에 많은 도움이 될 것으로 사료된다.